1 – 10 of 10
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A Modified Progressive Supranuclear Palsy Rating Scale
(
- Contribution to journal › Article
- 2020
-
Mark
Lack of Accredited Clinical Training in Movement Disorders in Europe, Egypt, and Tunisia
(
- Contribution to journal › Article
- 2019
-
Mark
Using global team science to identify genetic parkinson's disease worldwide
(
- Contribution to journal › Article
- 2017
-
Mark
The hidden Niemann-Pick type C patient : clinical niches for a rare inherited metabolic disease
(
- Contribution to journal › Article
-
Mark
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
(
- Contribution to journal › Scientific review
-
Mark
Clinical diagnosis of progressive supranuclear palsy : The movement disorder society criteria
(
- Contribution to journal › Article
- 2016
-
Mark
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
(
- Contribution to journal › Article
-
Mark
Deletions at 22q11.2 in idiopathic Parkinson's disease : a combined analysis of genome-wide association data
(
- Contribution to journal › Article
- 2015
-
Mark
Gene expression analyses identify narp contribution in the development of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
- 2014
-
Mark
Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for l-DOPA-induced dyskinesia
(
- Contribution to journal › Article